Mast cells contain a lot of mast cell-specific proteases. We have reported that the expression of mouse mast cell protease 6 (MMCP-6) is remarkably reduced in both cultured mast cells (CMCs) and skin mast cells of mi/mi mutant mice. In the present study, we found that the expression of MMCP-5 was reduced in CMCs but not in skin mast cells of mi/mi mice, and we compared the regulation mechanisms of MMCP-5 with those of MMCP-6. The mi locus encodes a member of the basic-helix-loop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF ). The consensus sequence recognized and bound by bHLH-Zip transcription factors is CANNTG. The overexpression of the normal (+) MITF but not of mi-MITF normalized the poor expression of the MMCP-5 gene in mi/mi CMCs, indicating the involvement of +-MITF in transactivation of the MMCP-5 gene. Although +-MITF directly bound CANNTG motifs in the promoter region of the MMCP-6 gene and transactivated it, the binding of +-MITF to the CAGTTG motif in the promoter region of the MMCP-5 gene was not detectable. The +-MITF appeared to regulate the transactivation of the MMCP-5 gene indirectly. Moreover, addition of stem cell factor to the medium normalized the expression of the MMCP-5 but not of the MMCP-6 gene in mi/mi CMCs. Despite the significant reduction of both MMCP-5 and MMCP-6 expressions in mi/mi CMCs, their regulation mechanisms appeared to be different.

THE MI LOCUS OF MICE on chromosome 6 encodes a member of the basic-helix-loop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called mi-transcription factor [MITF ]).1,2 The MITF encoded by the mutant mi locus deletes 1 of 4 consecutive arginines in the basic domain (hereafter mi-MITF ).1,3,4 The mi/mi mice show microphthalmia, depletion of pigment in both hair and eyes, osteopetrosis, and a decrease in the number of mast cells.5-9 In addition to the decrease in number, the phenotype of mast cells was abnormal in mi/mi mice.10-13 In the skin of normal (+/+) mice, most mast cells were stained with berberine sulfate that bound heparin proteoglycan,14-17 and half of them expressed the mouse mast cell protease 6 (MMCP-6) gene.11 In contrast, only a few mast cells were berberine sulfate-positive and MMCP-6 mRNA-positive in the skin of mi/mi mice.11 The expression of the MMCP-6 gene was remarkably reduced in cultured mast cells (CMCs) derived from the spleen of mi/mi mice as well.10 13 

We previously showed that normal (+) MITF (hereafter called +-MITF ) directly regulated the expression of the MMCP-6 and c-kit genes.18-20 The defect in the transactivation ability of mi-MITF caused the decrease of the MMCP-6 gene expression in mi/mi mice. The decrease of the mast cell number in tissues of mi/mi mice was attributed to the low expression of the c-kit gene, which encodes the receptor for stem cell factor (SCF ).9,10,18 We also showed that the deficient transactivation ability of the mi-MITF was caused by two different mechanisms: the loss of DNA binding and the impaired nuclear localization.19 21 

Mast cells of mice contain various proteases besides MMCP-6. The cDNAs and genes that encode mast cell carboxypeptidase A (MC-CPA) and six of the seven mouse mast cell-specific serine proteases (MMCP) have been cloned and sequenced.22-29 The MMCP-1, MMCP-2, MMCP-4, and MMCP-5 are predicted to be chymases, whereas the MMCP-6 and MMCP-7 to be tryptases from the deduced amino acid sequences. The MC-CPA is an exopeptidase that prefers C-terminal aliphatic amino acids. The MMCP-1, MMCP-2, MMCP-4, and MMCP-5 genes reside on the chromosome 14 and link with a gene complex encoding blood cell proteases, such as the neutrophil cathepsin G and four granzymes specific to cytotoxic T lymphocytes.30-33 On the other hand, the MC-CPA gene resides on the chromosome 3, and the MMCP-6 and MMCP-7 genes reside on the chromosome 17.29 The expression of MMCP-6 was strongly regulated by the +-MITF, but that of MC-CPA was not influenced by the +-MITF.20 In the present study, we studied the effect of the +-MITF on the expression of MMCP-5 and found that the +-MITF was involved in the transactivation of the MMCP-5 gene. However, the mechanism of the MMCP-5 regulation by the +-MITF appeared to be different from that of MMCP-6.

Mice. The original stock of C57BL/6-mi/+ (mi/+) mice was purchased from the Jackson Laboratory (Bar Harbor, ME) and were maintained in our laboratory by consecutive backcrosses to our own inbred C57BL/6 colony (more than 15 generations at the time of the present experiment). Female and male mi/+ mice were crossed together, and the resulting mi/mi mice were selected by their white coat color.5,6 The original stock of VGA-9-tg/tg mice, in which the mouse vasopressin-Escherichia coli β-galactosidase transgene was integrated at the 5′ flanking region of the mi (MITF ) gene, were kindly given by H. Arnheiter (National Institutes of Health, Bethesda, MD). The integrated transgene was maintained by repeated backcrosses to our own inbred C57BL/6 colony (more than 5 generations at the time of the present experiment). Female and male tg/+ mice were crossed together, and the resulting tg/tg mice were selected by their white coat color.1 

Cells. Pokeweed mitogen-stimulated spleen cell conditioned medium (PWM-SCM) was prepared according to the method described by Nakahata et al.34 Mice of mi/mi or tg/tg genotype and control C57BL/6-+/+ (+/+) mice were used at 2 to 3 weeks of age to obtain CMCs. Mice were killed by decapitation after ether anesthesia and spleens were removed. Spleen cells derived from mi/mi, tg/tg, or +/+ mice were suspended as described previously and cultured in α-minimal essential medium (α-MEM; ICN Biomedicals, Costa Mesa, CA) supplemented with 10% PWM-SCM and 10% fetal calf serum (FCS; Nippon Bio-supp Center, Tokyo, Japan). Half of the medium was replaced every 7 days. More than 95% of cells were CMCs 4 weeks after the initiation of the culture.16 A helper virus-free packaging cell line (ψ2) was maintained in Dulbecco's modification of Eagle's medium (DMEM; ICN Biomedicals) supplemented with 10% FCS.35 Mouse mastocytoma cell line, FMA/3, was maintained in α-MEM supplemented with 10% FCS.36 When various amounts of recombinant mouse SCF (rmSCF; a generous gift of Kirin Brewery Co Ltd, Tokyo, Japan) were added, mi/mi and +/+ CMCs were cultured in α-MEM containing 10% PWM-SCM and 10% FCS.

Construction of retrovirus and its infection. Bluescript KS(−) plasmids (pBS; Stratagene, La Jolla, CA) containing the whole coding regions of +-MITF or mi-MITF (hereafter called pBS-+-MITF and pBS-mi-MITF, respectively) had been constructed in our laboratory.19 A retroviral vector pM5Gneo,37 a derivative of myeloproliferative sarcoma virus vector, was a kind gift from Dr W. Ostertag (Universität Hamburg, Hamburg, Germany). The purified Sma I-HincII fragment from pBS-+-MITF or pBS-mi-MITF was introduced into the blunted EcoRI site of pM5Gneo. The resulting plasmids (hereafter called pM5Gneo-+-MITF and pM5Gneo-mi-MITF, respectively) or the pM5Gneo vector were transfected into the packaging cell line (ψ2) using the calcium phosphate method,38 and neomycin-resistant ψ2 cell clones were selected by culturing in DMEM containing 10% FCS and G418 (0.8 mg/mL; GIBCO BRL, Grand Island, NY). For the gene transfer, spleen cells obtained from mi/mi mice were incubated on irradiated (30 Gy) subconfluent monolayer of virus-producing ψ2 cells for 72 hours in α-MEM supplemented with 10% PWM-SCM and 10% FCS. Neomycin-resistant CMCs were obtained by continuing the culture in α-MEM containing 10% PWM-SCM, 10% FCS, and G418 (0.8 mg/mL) for 4 weeks. FMA/3 cells were infected with the retrovirus containing pM5Gneo-+-MITF, pM5Gneo-mi-MITF, or pM5Gneo plasmid by culturing on the virus-producing ψ2 cells. Neomycin-resistant FMA/3 cells were obtained by continuing the culture in α-MEM containing 10% FCS and G418 (0.8 mg/mL) for 4 weeks.

Northern blot analysis. Total RNAs were prepared using the lithium chloride-urea method.39 The fragments of MMCP-5,25 MC-CPA,23 MMCP-6,26 and β-actin40 cDNAs were used as probes after being labeled with [32P]-α-dCTP (DuPont/NEN Research Products, Boston, MA; 10 mCi/mL) by random oligonucleotide priming. After hybridization at 42°C, blots were washed to a final stringency of 0.2× SSC (1× SSC is 150 mmol/L NaCl, 15 mmol/L trisodium citrate, pH 7.4) at 50°C and subjected to autoradiography.

Reverse transcriptase modification of polymerase chain reaction (RT-PCR). Total RNA (5.0 μg) obtained from +/+ or mi/mi CMCs was reverse transcribed in 20 μL of the reaction mixture containing 20 U of avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim GmbH Biochemica, Mannheim, Germany) and random hexamer. One microliter of each reaction product was amplified in 25 μL of PCR mixture containing 0.125 U of Taq DNA polymerase (Takara Shuzou, Kyoto, Japan) and 12.5 pmol each of sense and antisense primers by 30 cycles of 1 minute of denaturation at 94°C, 2 minutes of annealing at 55°C, and 2 minutes of synthesis at 72°C. Ten microliters of the PCR products was electrophoresed in 1.0% agarose gel containing ethidium bromide. The following oligonucleotide primers were used: MMCP-5: sense primer, 5′-CTACATGGCCTATCTGGAAA (130 through 149), antisense primer, 5′-TCCAGTTCCAGATTTCCTCA (795 through 814); MMCP-6: sense primer, 5′-TGTCCCTGAGCATTCCTGAGACCTA (1509 through 1533), antisense primer, 5′-TACTTTAATGAGCCACAGAAGAGAG (1738 through 1762); MC-CPA: sense primer, 5′-GTGATGACTGCTGCACACTG (194 through 213), antisense primer, 5′-CTTGAAGAGTCTGACTCAGG (769 through 788). The numbers represent the nucleotide numbers on the complementary strands of each cDNA sequence.23,25 26 

In situ hybridization. Skin pieces were removed from the back of 20-day-old mice and smoothed onto a piece of the filter paper to keep them flat. The skin pieces were fixed in 4% paraformaldehyde in 0.1 mol/L phosphate buffer (PB; pH 7.4), and embedded in paraffin. CMCs were collected, washed with phosphate-buffered saline, and immobilized by agarose.41 The pieces of agarose-containing CMCs were fixed with 4% paraformaldehyde in 0.1 mol/L PB overnight and then embedded in paraffin. The preparation of MMCP-5, MMCP-6, and MC-CPA probes and the technique of in situ hybridization were described previously.11 42 The number of MMCP-5 mRNA-positive cells and that of Alcian blue-positive cells were counted in the serial sections, and the proportion of MMCP-5 mRNA-positive cells to Alcian blue-positive cells was calculated. The proportion of MMCP-6 mRNA-positive cells and that of MC-CPA mRNA-positive cells were also obtained.

Isolation of the promoter region of the MMCP-5 gene. The isolation of the promoter region of MMCP-5 gene was performed with the Mouse Promoter Finder Kit (Clonetech Laboratories, Palo Alto, CA) according to the manufacturer's instructions. The isolated promoter region was cloned into pBS and sequenced.

Construction of reporter plasmids. The luciferase gene subcloned into pSP72 (pSPLuc) was generously provided by Dr K. Nakajima (Osaka University Medical School, Osaka, Japan).43 To construct reporter plasmids, a DNA fragment containing a promoter region and the first exon (noncoding region) of the MMCP-5 gene (−2212 to +30) was cloned into the upstream of luciferase gene in pSPLuc. The deletion of the MMCP-5 promoter was produced by using the appropriate restriction enzyme. The mutation was introduced by PCR with mismatch primers. Deleted or mutated products were verified by sequencing.

Transfection of reporter plasmids and luciferase assay. Ten micrograms of reporter plasmid and 1 μg of pSTneo were transfected to 107 FMA/3 cells with electroporation (BioRad, Hercules, CA; 975 μF, 350 V). Neomycin-resistant cells were obtained by continuing the culture in α-MEM containing 10% FCS and G418 (0.8 mg/mL) for 4 weeks. The genomic DNA was extracted from neomycin-resistant cells, and the copy number of the luciferase gene was examined with the Southern blot analysis. For the assay of the luciferase activity, the cells were lysed with 0.1 mol/L potassium phosphate buffer (pH 7.4) containing 1% Triton X-100. Soluble extracts were then assayed for luciferase activity with a luminometer LB96P (Berthold GmbH, Wildbad, Germany). The activity was normalized by the copy number of the integrated luciferase gene and total protein concentration. When the reporter plasmids were transfected to FMA/3 cells infected by retrovirus containing pM5Gneo-+-MITF, pM5Gneo-mi-MITF, or pM5Gneo, the hygromycin-resistant gene was cotransfected. The hygromycin-resistant cells were selected by culturing in α-MEM containing 10% FCS and hygromycin (2 mg/mL) for 4 weeks.

Electrophoretic gel mobility shift assay (EGMSA). The production and purification of glutathione-S-transferase (GST)-+-MITF fusion protein was described previously.19 The nuclear extract from FMA/3 cells overexpressing +-MITF or mi-MITF was obtained by the method described by Schreiber et al.44 The whole cell extract was obtained by the method described by Pagano et al.45 Oligonucleotides were labeled with α-[32P]-dCTP by filling 5′-overhangs and used as probes of EGMSA. DNA-binding assays were performed in a 20 μL reaction mixture containing 10 mmol/L Tris-HCl (pH 8.0), 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 75 mmol/L KCl, 1 mmol/L dithiothreitol, 4% Ficoll type 400, 50 ng of poly (dI-dC), 25 ng of labeled DNA probe, and 3.5 μg of GST-+-MITF fusion protein, nuclear extract, or whole cell extract. After incubation at room temperature for 15 minutes, the reaction mixture was subjected to electrophoresis at 14 V/cm at 4°C on a 5% polyacrylamide gel in 0.25× TBE buffer (1× TBE is 90 mmol/L Tris-HCl, 64.6 mmol/L boric acid, and 2.5 mmol/L EDTA, pH 8.3). The polyacrylamide gels were dried on Whatman 3MM chromatography paper (Whatman, Maidstone, UK) and subjected to autoradiography.

Impaired MMCP-5 expression in mi/mi CMCs but not in mi/mi skin mast cells. The expression of the MMCP-5 gene was examined by Northern blot using total RNA extracted from +/+, mi/mi, and tg/tg CMCs. The mRNA expression of the MMCP-5 gene was easily detectable in +/+ CMCs but hardly detectable in mi/mi and in tg/tg CMCs (Fig 1). As reported previously, the expression of MMCP-6 gene showed the similar expression pattern to that of the MMCP-5 gene,20 and the expression of the MC-CPA gene did not decrease in mi/mi and tg/tg CMCs (Fig 1).10 We introduced the cDNA encoding +-MITF or mi-MITF to mi/mi CMCs. The magnitude of mRNA expression of +-MITF was comparable to that of mi-MITF, and the expression level of introduced +- or mi-MITF was much greater than that of endogenous mi-MITF. We examined the MMCP-5 mRNA expression in mi/mi CMCs overexpressing +-MITF and mi/mi CMCs overexpressing mi-MITF (Fig 1). The expression of the MMCP-5 mRNA recovered to the nearly normal level in mi/mi CMCs overexpressing +-MITF but not in mi/mi CMCs overexpressing mi-MITF. The expression of the MMCP-6 mRNA showed the similar pattern to that of the MMCP-5 mRNA. The introduction of +- or mi-MITF cDNA did not affect the mRNA expression of the MC-CPA, as reported previously.20 

Fig. 1.

Reduced expression of MMCP-5 mRNA in mi/mi and tg/tg CMCs and normalization of the MMCP-5 expression in mi/mi CMCs by the introduction of the +-MITF cDNA but not of mi-MITF cDNA. The blot was hybridized with 32P-labeled cDNA probe of MMCP-5, MMCP-6, or MC-CPA.

Fig. 1.

Reduced expression of MMCP-5 mRNA in mi/mi and tg/tg CMCs and normalization of the MMCP-5 expression in mi/mi CMCs by the introduction of the +-MITF cDNA but not of mi-MITF cDNA. The blot was hybridized with 32P-labeled cDNA probe of MMCP-5, MMCP-6, or MC-CPA.

Close modal

We next examined the expression of the MMCP-5 gene in skin mast cells of mi/mi mice by in situ hybridization. Approximately half of the skin mast cells expressed the MMCP-5 mRNA in both +/+ and mi/mi mice (Table 1 and Fig 2). Because mast cells in the skin were considered to be supported by SCF synthesized by fibroblasts,17 rmSCF was added to the culture medium of mi/mi and +/+ CMCs. The CMCs of mi/mi genotype do not proliferate in the medium containing rmSCF alone.10 Thus, we added PWM-SCM to the culture medium as well. After the incubation with 10 or 50 ng/mL of rmSCF for 2 weeks, we examined the proportion of mi/mi CMCs expressing the MMCP-5, MMCP-6, or MC-CPA mRNA by in situ hybridization (Table 2). The proportion of mi/mi CMCs expressing the MMCP-5 mRNA increased significantly even in the presence of 10 ng/mL rmSCF (Table 2). In contrast, the proportion of mi/mi CMCs expressing the MMCP-6 or MC-CPA mRNA was not influenced by the addition of rmSCF. The proportion of +/+ CMCs expressing the MMCP-5, MMCP-6, or MC-CPA mRNA was not affected by the addition of rmSCF to the culture medium (Table 2).

Table 1.

Proportion of MMCP-5-mRNA Expressing Mast Cells in the Skin of +/+ and mi/mi Mice Shown by In Situ Hybridization

Genotype of MiceNo. of MiceNo. ofNo. ofProportion of
Alcian Blue+ CellsMMCP-5 mRNA+MMCP-5 mRNA+ to
per cm of Skin*Cells per cm of Skin*Alcian Blue+ Cells (%)*
+/+ 228 ± 9 127 ± 6 56 ± 3 
mi/mi 47 ± 13 27 ± 9 57 ± 4 
Genotype of MiceNo. of MiceNo. ofNo. ofProportion of
Alcian Blue+ CellsMMCP-5 mRNA+MMCP-5 mRNA+ to
per cm of Skin*Cells per cm of Skin*Alcian Blue+ Cells (%)*
+/+ 228 ± 9 127 ± 6 56 ± 3 
mi/mi 47 ± 13 27 ± 9 57 ± 4 
*

Mean ± SE.

P < .01 by t-test when compared with the value of +/+ mice.

Fig. 2.

Mast cells expressing MMCP-5 or MMCP-6 mRNA in the skin of +/+ and mi/mi mice. Serial sections from the skin of a +/+ mouse (A and B, E and H) and a mi/mi mouse (C and D, G and H). (A, C, E, and G) Stained with alcian blue and nuclear fast red; (B and D) in situ hybridization with MMCP-5 probe; (F and H) in situ hybridization with MMCP-6 probe. Arrowheads show identical cells in each set of serial sections. Original magnification × 400.

Fig. 2.

Mast cells expressing MMCP-5 or MMCP-6 mRNA in the skin of +/+ and mi/mi mice. Serial sections from the skin of a +/+ mouse (A and B, E and H) and a mi/mi mouse (C and D, G and H). (A, C, E, and G) Stained with alcian blue and nuclear fast red; (B and D) in situ hybridization with MMCP-5 probe; (F and H) in situ hybridization with MMCP-6 probe. Arrowheads show identical cells in each set of serial sections. Original magnification × 400.

Close modal
Table 2.

Effect of rmSCF on Proportions of CMCs Expressing MMCP-5, MMCP-6, or MC-CPA mRNA in +/+ or mi/mi CMCs Shown by In Situ Hybridization

Genotype of CMCsConcentration of rmSCFProportion ofProportion ofProportion of MC-CPA mRNA+ to Alcian Blue+ Cells (%)
(ng/mL)*MMCP-5 mRNA+ to Alcian Blue+ Cells (%)MMCP-6 mRNA+ to Alcian Blue+ Cells (%)
+/+ 45 ± 2 44 ± 3 92 ± 5 
mi/mi 4 ± 3 3 ± 1 86 ± 4 
+/+ 10 54 ± 7 52 ± 6 93 ± 3 
mi/mi 10 41 ± 4ρ 5 ± 4 85 ± 5 
+/+ 50 52 ± 6 53 ± 7 86 ± 7 
mi/mi 50 38 ± 4ρ 5 ± 2 82 ± 6 
Genotype of CMCsConcentration of rmSCFProportion ofProportion ofProportion of MC-CPA mRNA+ to Alcian Blue+ Cells (%)
(ng/mL)*MMCP-5 mRNA+ to Alcian Blue+ Cells (%)MMCP-6 mRNA+ to Alcian Blue+ Cells (%)
+/+ 45 ± 2 44 ± 3 92 ± 5 
mi/mi 4 ± 3 3 ± 1 86 ± 4 
+/+ 10 54 ± 7 52 ± 6 93 ± 3 
mi/mi 10 41 ± 4ρ 5 ± 4 85 ± 5 
+/+ 50 52 ± 6 53 ± 7 86 ± 7 
mi/mi 50 38 ± 4ρ 5 ± 2 82 ± 6 
*

+/+ or mi/mi CMCs were incubated with 10% PWM-SCM and various concentrations of rmSCF for 2 weeks.

Mean ± SE of five independent experiments.

P < .01 by t-test when compared with the value of +/+ CMCs, which were cultured without rmSCF.

ρ P < .01 by t-test when compared with the value of mi/mi CMCs, which were cultured without rmSCF.

We examined the effect of duration of rmSCF exposure on induction of the MMCP-5 mRNA expression by Northern blotting and RT-PCR technique. The MMCP-5 mRNA expression was not detectable in mi/mi CMCs that were cultured with 10% PWM-SCM alone by the Northern blotting, but a weak band was detectable by RT-PCR (Fig 3). One week after initiation of the culture with 10% PWM-SCM and 10 ng/mL rmSCF, the message became detectable even by Northern blotting. The level of MMCP-5 expression increased until 2 weeks after the addition of rmSCF. The expression of MMCP-5 mRNA in +/+ CMCs was not influenced by the addition of rmSCF. The expression of MMCP-6 mRNA was not detectable in mi/mi CMCs by the Northern blotting, but weak band was detectable by RT-PCR. In contrast to MMCP-5, the magnitude of MMCP-6 expression was not influenced by the addition of rmSCF (Fig 3).

Fig. 3.

Effect of the addition of rmSCF on the expression of MMCP-5, MMCP-6, or MC-CPA gene in +/+ and mi/mi CMCs. (A) Northern blotting. Total RNA was obtained from +/+ or mi/mi CMCs cultured in the presence of 10% PWM-SCM and 10 ng/mL SCF for 0, 1, 2, or 3 weeks. The blot was hybridized with 32P-labeled cDNA probes for MMCP-5, MMCP-6, and MC-CPA. (B) RT-PCR analysis for the expression of MMCP-5, MMCP-6, or MC-CPA gene. The same RNAs were used as those used in Northern blotting. PCR products were electrophoresed in 1.0% agarose gel containing ethidium bromide.

Fig. 3.

Effect of the addition of rmSCF on the expression of MMCP-5, MMCP-6, or MC-CPA gene in +/+ and mi/mi CMCs. (A) Northern blotting. Total RNA was obtained from +/+ or mi/mi CMCs cultured in the presence of 10% PWM-SCM and 10 ng/mL SCF for 0, 1, 2, or 3 weeks. The blot was hybridized with 32P-labeled cDNA probes for MMCP-5, MMCP-6, and MC-CPA. (B) RT-PCR analysis for the expression of MMCP-5, MMCP-6, or MC-CPA gene. The same RNAs were used as those used in Northern blotting. PCR products were electrophoresed in 1.0% agarose gel containing ethidium bromide.

Close modal

The analysis of the promoter region of MMCP-5 gene. The result that the introduction of +-MITF cDNA normalized the impaired MMCP-5 expression in mi/mi CMCs indicated the involvement of +-MITF in the regulation of the MMCP-5 gene expression. To examine the regulation mechanism by the +-MITF, we cloned 2212 bases of the 5′-upstream region of the MMCP-5 gene (Fig 4). The reporter plasmid that contained the luciferase gene under the control of the MMCP-5 promoter starting from nt −2212 (+1 shows the transcription initiation site) was constructed. We also constructed the deleted reporter plasmids containing the MMCP-5 promoter starting from nt −924, −470, or −178 to examine the elements that mediate the transactivation. The reporter plasmids were transfected into the FMA/3 mastocytoma cells, which expressed the +-MITF and MMCP-5 mRNAs. When the reporter plasmid containing the MMCP-5 promoter starting from nt −2212 was introduced, the FMA/3 cells showed the low luciferase activity. On the other hand, when the reporter plasmid containing the MMCP-5 promoter starting from nt −924 was introduced, the luciferase activity increased approximately 30-fold (Fig 5). The reporter plasmid starting from nt −470 also showed a comparable level of the luciferase activity in FMA/3 cells. However, when the reporter plasmid starting from nt −178 was introduced, the luciferase gene was not transactivated (Fig 5). There was only one CANNTG motif in the MMCP-5 promoter region starting from nt −470, ie, CAGTTG between nt −204 and nt −199. The CANNTG motif is recognized by the bHLH-Zip protein family of transcription factors, including MITF.46 We mutated the CAGTTG motif to CTGTAG in the reporter plasmid starting from nt −470. The mutation abolished the transactivation ability of the MMCP-5 promoter in FMA/3 cells (Fig 5).

Fig. 4.

The nucleotide sequence of 5′ flanking region of the MMCP-5 gene. The CANNTG motif was boxed. A part of the first exon is shown by capitals, and the 5′ flanking region is shown by lower case. The transcription initiation site was numbered as +1.

Fig. 4.

The nucleotide sequence of 5′ flanking region of the MMCP-5 gene. The CANNTG motif was boxed. A part of the first exon is shown by capitals, and the 5′ flanking region is shown by lower case. The transcription initiation site was numbered as +1.

Close modal
Fig. 5.

Luciferase activity in FMA/3 cells under the control of the normal, deleted, or mutated MMCP-5 promoter. The value of the luciferase activity was divided by the value obtained with the reporter plasmid starting at nt −178 and is shown as the relative luciferase activity. The data represent the mean ± standard error (SE) of three experiments. In some cases, the SE was too small to be shown by the bars.

Fig. 5.

Luciferase activity in FMA/3 cells under the control of the normal, deleted, or mutated MMCP-5 promoter. The value of the luciferase activity was divided by the value obtained with the reporter plasmid starting at nt −178 and is shown as the relative luciferase activity. The data represent the mean ± standard error (SE) of three experiments. In some cases, the SE was too small to be shown by the bars.

Close modal

Effect of overexpression of mi-MITF on the MMCP-5 promoter. The luciferase gene under the control of the MMCP-5 promoter was transfected into FMA/3 cells overexpressing +- or mi-MITF. Because there is a possibility that the transcriptional activity in the FMA/3 cells infected with the retrovirus is different from that of the original FMA/3 cells, the FMA/3 cells infected with the retrovirus containing the vector alone were used as a control. When the reporter plasmid starting from nt −470 was transfected, the high luciferase activity was observed in the FMA/3 cells overexpressing the +-MITF (Fig 6). The value was comparable to the value observed in FMA/3 cells containing the retroviral vector alone (Fig 6). In contrast, when the same plasmid was transfected into FMA/3 cells overexpressing the mi-MITF, luciferase activity was hardly detectable (Fig 6). The deletion to nt −178 or the mutation at the CAGTTG motif to CTGTAG resulted in the abolishment of the luciferase activity in all three types of FMA/3 cells.

Fig. 6.

The effect of overexpression of +- or mi-MITF on the luciferase activity in FMA/3 cells. The luciferase gene under the control of the normal, deleted, or mutated MMCP-5 promoter was transfected to the FMA/3 cells overexpressing +- or mi-MITF or to the FMA/3 cells containing the retroviral vector (pM5Gneo) alone. The data represent the mean ± SE of three experiments. In some cases, the SE was too small to be shown by the bars.

Fig. 6.

The effect of overexpression of +- or mi-MITF on the luciferase activity in FMA/3 cells. The luciferase gene under the control of the normal, deleted, or mutated MMCP-5 promoter was transfected to the FMA/3 cells overexpressing +- or mi-MITF or to the FMA/3 cells containing the retroviral vector (pM5Gneo) alone. The data represent the mean ± SE of three experiments. In some cases, the SE was too small to be shown by the bars.

Close modal

EGMSA with the CAGTTG motif as a probe. The transfection assay using the deleted or mutated reporter plasmids suggested a possibility that the CAGTTG motif mediated the transactivation ability of the +-MITF. First, we examined the binding of +-MITF to the oligonucleotide containing the CAGTTG motif. The purified GST-+-MITF fusion protein did not bind the oligonucleotide (Fig 7A). Moreover, the binding of GST-+-MITF fusion protein to the CACATG motif in the MMCP-6 promoter was not competed with the excess amount of the nonlabeled oligonucleotide containing the CAGTTG motif.

Fig. 7.

EGMSA using GST-+-MITF fusion protein or using the nuclear extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. (A) Nonbinding of GST-+-MITF to the CAGTTG motif in the MMCP-5 promoter. The labeled 5′-ACAGAGGCACAGTTGAGGACCTAT oligonucleotide in the MMCP-5 promoter (oligo 1) or the labeled 5′-TGGTGGGGACACATGTTACATGGA oligonucleotide in the MMCP-6 promoter (oligo 3) was used as a probe (each hexameric motif is boxed in the figure). Competition for the binding of GST-+-MITF to the labeled oligo 3 was also examined. The excess amount of nonlabeled oligo 1 or oligo 3 was added. The binding was inhibited by nonlabeled oligo 3 but not by nonlabeled oligo 1. (B) EGMSA using nuclear extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. Oligo 1 was used as a probe. The excess amount of nonlabeled oligo 1 or the nonlabeled oligonucleotide mutated at the CAGTTG motif (to CTGTAG, oligo 2) was added. The binding was inhibited by nonlabeled oligo 1 but not by nonlabeled oligo 2. (C) EGMSA using whole cell extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. Oligo 1 was used as a probe. The excess amount of nonlabeled oligo 1 or oligo 2 was added.

Fig. 7.

EGMSA using GST-+-MITF fusion protein or using the nuclear extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. (A) Nonbinding of GST-+-MITF to the CAGTTG motif in the MMCP-5 promoter. The labeled 5′-ACAGAGGCACAGTTGAGGACCTAT oligonucleotide in the MMCP-5 promoter (oligo 1) or the labeled 5′-TGGTGGGGACACATGTTACATGGA oligonucleotide in the MMCP-6 promoter (oligo 3) was used as a probe (each hexameric motif is boxed in the figure). Competition for the binding of GST-+-MITF to the labeled oligo 3 was also examined. The excess amount of nonlabeled oligo 1 or oligo 3 was added. The binding was inhibited by nonlabeled oligo 3 but not by nonlabeled oligo 1. (B) EGMSA using nuclear extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. Oligo 1 was used as a probe. The excess amount of nonlabeled oligo 1 or the nonlabeled oligonucleotide mutated at the CAGTTG motif (to CTGTAG, oligo 2) was added. The binding was inhibited by nonlabeled oligo 1 but not by nonlabeled oligo 2. (C) EGMSA using whole cell extract obtained from FMA/3 cells overexpressing +-MITF or mi-MITF. Oligo 1 was used as a probe. The excess amount of nonlabeled oligo 1 or oligo 2 was added.

Close modal

We then examined whether the nuclear extract from FMA/3 cells overexpressing +- or mi-MITF contained proteins that bound the oligonucleotide with the CAGTTG motif. The protein-DNA complex was made when the oligonucleotide containing the CAGTTG motif was incubated with the nuclear extract from FMA/3 cells overexpressing either +-MITF or mi-MITF. However, the amount of the protein-DNA complex was significantly greater in the nuclear extract from the FMA/3 cells overexpressing +-MITF than in the nuclear extract from the FMA/3 cells overexpressing mi-MITF (Fig 7B). The amount of the protein-DNA complex was reduced by the addition of the excess amount of the nonlabeled oligonucleotide containing the CAGTTG motif, whereas the amount of the complex was not reduced by the addition of the excess amount of the oligonucleotide whose CAGTTG motif was mutated to CTGTAG.

We then performed a similar experiment using the whole cell extract instead of the nuclear extract. The whole cell extract was obtained from FMA/3 cells overexpressing +- or mi-MITF. The amount of protein-DNA complex was compared. Despite the remarkable difference in the amount of nuclear protein-DNA complex between FMA/3 cells overexpressing +-MITF and FMA/3 cells overexpressing mi-MITF, the amount was comparable between the whole cell extract obtained from these two types of FMA/3 cells (Fig 7C). The binding was specific because the addition of the excess amount of nonlabeled oligonucleotide containing CAGTTG abolished the binding (Fig 7C).

We examined the possibility that the protein that bound the oligonucleotide with the CAGTTG motif might be MITF, USF1, USF2, MYC, or FOS using specific antibodies. Any antibodies tested did not interfere with the formation of the protein-DNA complex (data not shown).

The expression of MMCP-5 was deficient in mi/mi CMCs and tg/tg CMCs. The poor expression of MMCP-5 mRNA in mi/mi CMCs is reminiscent of the poor expression of MMCP-6.20 However, the character of MMCP-5 as the protease is different from that of MMCP-6; MMCP-5 is a chymase, whereas the MMCP-6 is a tryptase.22 The protease mRNA expression phenotype of +/+ CMCs is influenced by various growth factors.29,47,48 Interleukin-4 (IL-4) inhibits the SCF-induced expression of the MMCP-4 gene in +/+ CMCs and the IL-10–induced expression of MMCP-1 and MMCP-2 genes in +/+ CMCs.47 Although IL-4 and IL-3 do not influence the MMCP-5 expression,47,48 Eklund et al47 reported that SCF increased the amount of MMCP-5 mRNA in +/+ CMCs. This is inconsistent with the present result that the addition of SCF did not remarkably influence the MMCP-5 mRNA expression in +/+ CMCs. The discrepancy may be attributable to the different concentrations of SCF and different mouse strains used. Eklund et al47 used 200 ng/mL of rmSCF and CMCs derived from BALB/c strain, whereas we used 10 ng/mL of rmSCF and CMCs from C57BL/6 strain. Further studies are necessary to clarify the discrepancy. Even if SCF potentiates the MMCP-5 mRNA expression in +/+ CMCs, we consider that the phenomenon is more apparent in mi/mi CMCs than in +/+ CMCs. The overexpression of +-MITF but not of mi-MITF in mi/mi CMCs normalized the transcription of the MMCP-5 gene. This apparently indicated that the +-MITF played an important role for the expression of the MMCP-5 gene.

Xia et al49 reported that MMCP-2 is posttranscriptionally regulated by IL-10. They indicated that IL-10 induces expression of a trans-acting factor(s) that stabilizes the MMCP-2 mRNA or facilitates its processing. As a result, the amount of MMCP-2 mRNA is greater in the presence of IL-10 than in its absence. In the present study, we indicated that SCF increased the amount of MMCP-5 mRNA. There is a possibility that MMCP-5 may be posttranscriptionally regulated by SCF. In contrast to MMCP-5, the addition of SCF did not increase the amount of MMCP-6 mRNA. This suggested that the regulational mechanism of MMCP-5 expression was different from that of MMCP-6. Further analysis such as nuclear run-on assay will clarify the transcriptional or posttranscriptional regulation of MMCP-5 expression.

The transfection of the reporter plasmid starting from nt −470 of the MMCP-5 promoter into the FMA/3 cells resulted in the high luciferase activity. This also indicated that the +-MITF was strongly involved in the transactivation of the MMCP-5 gene, because FMA/3 cells expressed +-MITF. The +-MITF induces the expression of various mast cell-specific genes18-20 and melanocyte-specific genes.50-53 The reporter activity increases when the +-MITF cDNA was coexpressed with the reporter gene under the control of the promoter of the MMCP-6,19,20 c-kit,18 tyrosinase,50 or tyrosinase related protein 1 (TRP-1) gene.51,52 The stable transfection of the +-MITF cDNA converted NIH/3T3 fibroblasts to the cells with melanocyte characteristics that expressed the tyrosinase and TRP1 genes.53 However, little is known about the molecular mechanism of the transactivation by the +-MITF, except for the cases of the c-kit18  and the MMCP-6 genes.20 We previously reported that the MMCP-6 expression was transactivated by the binding of +-MITF to the CANNTG motifs in the promoter region.19 20 Because the MMCP-5 and MMCP-6 genes showed the similar expression pattern in mi/mi or tg/tg CMCs or in mi/mi CMCs overexpressing +-MITF, we speculated that the +-MITF might transactivate the MMCP-5 gene by the direct binding, as observed in the case of the MMCP-6 gene. Only one CANNTG motif was present in the 2212 bases of the MMCP-5 promoter region, ie, the CAGTTG motif between nt −204 and −199. The reporter plasmid whose CAGTTG motif was mutated to CTGTAG lacked the luciferase activity completely in FMA/3 cells. This indicated the significance of the CAGTTG motif for the expression of the MMCP-5 gene.

However, EGMSA showed that the GST-+-MITF fusion protein did not bind the CAGTTG motif between −204 and −199 of the MMCP-5 promoter. We examined whether proteins that bound the CAGTTG motif were present in the nuclear extract from the FMA/3 cells overexpressing +-MITF. At least a protein that bound the CAGTTG motif was detectable. The addition of the anti-MITF antibody did not influence the formation of the protein-DNA complex. This suggested that the protein that bound the CAGTTG motif in the nuclear extract did not form a complex with the +-MITF. Many examples of indirect interactions between transcription factors and the cis-elements have been reported.54-56 The Id proteins that lack the DNA binding domain bind bHLH-Zip transcription factors such as myoD and E2A and inhibit the binding of these bHLH-Zip proteins to DNA.54 The I-κB proteins form complexes with the active form of NF-κB proteins and sequester them in the cytoplasm, keeping them in the latent form.55 56 These transcription factors do not bind DNA itself, but they function by associating with other intermediate proteins. There is a possibility that the +-MITF may indirectly interact with the CAGTTG motif through the CAGTTG-binding protein detected in the nuclear extract.

The amount of the CAGTTG-binding protein was smaller in the nuclear extract of the FMA/3 cells overexpressing mi-MITF than in the nuclear extract of the FMA/3 cells overexpressing +-MITF (Fig 7B). This may be consistent with another result that the transactivation of the luciferase gene under the control of the MMCP-5 promoter was suppressed by the overexpression of mi-MITF in FMA/3 cells (Fig 6). The amount of the CAGTTG-binding protein in the nucleus may be regulated by the following two mechanisms. (1) The +-MITF may regulate the transcription of the gene encoding the CAGTTG-binding protein. (2) The +-MITF may regulate the nuclear transport of the CAGTTG-binding protein. The second mechanism is consistent with our previous finding that the mi-MITF inhibited the nuclear transport of +-MITF.21 In fact, the amount of the CAGTTG-binding protein was comparable between the whole cell extract from FMA/3 cells overexpressing +-MITF and that of FMA/3 cells overexpressing mi-MITF (Fig 7C). On the other hand, the amount of the CAGTTG-binding protein was apparently larger in the nuclear extract of FMA/3 cells overexpressing +-MITF than in the nuclear extract of FMA/3 cells overexpressing mi-MITF. Taken together, it was suggested that the CAGTTG-binding protein remained in the cytoplasm of FMA/3 cells overexpressing mi-MITF. The +-MITF appeared to be necessary for the nuclear transport of the CAGTTG-binding protein. In other words, the overexpression of the mi-MITF may inhibit the nuclear transport of the CAGTTG-binding protein. Recently Nechushtan et al57 reported that +-MITF was associated with USF2. We examined whether the anti-USF2 antibody bound CAGTTG-binding protein, but no binding was observed. The identification of the CAGTTG-binding protein might clarify the molecular mechanism of the transactivation of the MMCP-5 gene through the +-MITF. The present result at least indicates that the transactivation mechanism of the MMCP-5 gene is different from that of the MMCP-6 gene.

The addition of SCF to the culture medium significantly increased the proportion of mi/mi CMCs that expressed MMCP-5 mRNA. The expression of c-kit gene was decreased in mi/mi CMCs, but it was not completely abolished.18 SCF appeared to be able to stimulate mi/mi CMCs through the moderately expressed c-kit receptors. Eklund et al58 reported that CMCs derived from W/Wv mice, in which the function of c-kit receptor was severely impaired, expressed nearly normal levels of MMCP-5 mRNA. The MMCP-5 gene expression appeared to be regulated by at least two mechanisms: the c-kit-mediated signal transduction and the MITF-mediated one. When one of the two mechanisms functions normally, the MMCP-5 gene may be expressed. In mi/mi CMCs, the former was moderately impaired, and the latter was severely impaired. This may result in the abolishment of the MMCP-5 expression in mi/mi CMCs. The addition of SCF may make the former mechanism functional and increase the MMCP-5 expression in mi/mi CMCs.

In contrast to mi/mi CMCs, mi/mi skin mast cells expressed MMCP-5 mRNA. SCF synthesized by fibroblasts may induce the MMCP-5 expression in mi/mi skin mast cells. The different pattern of MMCP-5 expression between mi/mi CMCs and mi/mi skin mast cells may be attributable to the different concentration of SCF surrounding mast cells. The addition of SCF did not increase the MMCP-6 mRNA-expressing CMCs in mi/mi CMCs, and the skin mast cells in mi/mi mice did not express the MMCP-6 gene.11 These results indicated that SCF did not induce the MMCP-6 gene expression in mi/mi mast cells. The regulatory mechanisms of the MMCP-5 gene expression are apparently different from those of the MMCP-6 gene expression. The MMCP-5 gene is a good model to investigate the regulation of gene expression that is influenced by both transcription factors and growth factors.

The authors thank Dr S. Nomura (Osaka University) and Dr M. Yamamoto (Tsukuba University, Tsukuba, Japan) for valuable discussions, Dr H. Arnheiter for VGA9-tg/tg mice, Dr K. Nakajima for pSPLuc, and Kirin Brewery Co Ltd for rmSCF.

Supported by grants from the Ministry of Education, Science and Culture.

Address reprint requests to Yukihiko Kitamura, MD, Department of Pathology, Osaka University Medical School, Yamada-oka 2-2, Suita 565, Japan.

1
Hodgkinson
CA
Moore KJ
Nakayama
A
Steingrimsson
E
Copeland
NG
Jenkins
NA
Arnheiter
H
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein.
Cell
74
1993
395
2
Hughes
JJ
Lingrel
JB
Krakowsky
JM
Anderson
KP
A helix-loop-helix transcription factor-like gene is located at the mi locus.
J Biol Chem
268
1993
20687
3
Hemesath
TJ
Streingrimsson
E
McGill
G
Hansen
MJ
Vaught
J
Hodgikinson
CA
Arnheiter
H
Copeland
NG
Jenkins
NA
Fisher
DE
Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.
Genes Dev
8
1994
2770
4
Steingrimsson
E
Moore
KJ
Lamoreux
ML
Ferre-D'Amare
AR
Burley
SK
Zimring
DCS
Skow
LC
Hodgikinson
CA
Arnheiter
H
Copeland
NG
Jenkins
NA
Molecular basis of mouse microphthalmia (mi ) mutations helps explain their developmental and phenotypic consequences.
Nat Genet
8
1994
256
5
Silvers WK: The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction. New York, NY, Springer-Verlag, 1979, p 268
6
Green MC: Catalog of mutant genes and polymorphic loci, in Lyon MF, Searle AG (ed): Genetic Variants and Strains of the Laboratory Mouse. Stuttgart, Germany, Gustav Fischer Verlag, 1981, p 158
7
Stevens
J
Loutit
JF
Mast cells in spotted mutant mice (W, Ph, mi ).
Proc R Soc Lond
215
1982
405
8
Stechschulte
DJR
Sharma
KN
Dileepan
KM
Simpson
N
Aggarwal
J
Clancy
JR
Jilka
RL
Effect of the mi allele on mast cells, basophils, natural killer cells, and osteoclasts in C57BL/6J mice.
J Cell Physiol
132
1987
565
9
Ebi
Y
Kasugai
T
Seino
Y
Onoue
H
Kanemoto
T
Kitamura
Y
Mechanism of mast cell deficiency in mutant mice of mi/mi genotype: An analysis by co-culture of mast cells and fibroblasts.
Blood
75
1990
1247
10
Ebi
Y
Kanakura
Y
Jippo-Kanemoto
T
Tsujimura
T
Furitsu
T
Ikeda
H
Adachi
S
Kasugai
T
Nomura
S
Kanayama
Y
Yamatodani
A
Nishikawa
SI
Kitamura
Y
Low c-kit expression of cultured mast cells of mi/mi genotype may be involved in their defective responses to fibroblasts that express the ligand for c-kit.
Blood
80
1992
1454
11
Kasugai
T
Oguri
K
Jippo-Kanemoto
T
Morimoto
M
Yamatodani
A
Yoshida
K
Ebi
Y
Isozaki
K
Tei
H
Tsujimura
T
Nomura
S
Okayama
M
Kitamura
Y
Deficient differentiation of mast cells in the skin of mi/mi mice:usefulness of in situ hybridization for evaluation of mast cell phenotype.
Am J Pathol
143
1993
1337
12
Isozaki
K
Tsujimura
T
Nomura
S
Morii
E
Koshimizu
U
Nishimune
Y
Kitamura
Y
Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype.
Am J Pathol
145
1994
827
13
Jippo
T
Ushio
H
Hirota
S
Mizuno
H
Yamatodani
A
Nomura
S
Matsuda
H
Kitamura
Y
Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor.
Blood
84
1994
2977
14
Enerbäck
L
Berberine sulfate binding to mast cell polyanions: A cytofluorometric method for the quantitation of heparin.
Histochemistry
42
1974
301
15
Dimlich
RVX
Meineke
HA
Reilly
FD
McCuskey
RS
The fluorescent staining of heparin in mast cells using berberine sulfate: Compatibility with paraformaldehyde or o-phthalaldehyde induced-fluorescence and metachromasia.
Stain Technol
55
1980
217
16
Nakano
T
Sonoda
T
Hayashi
C
Yamatodani
A
Kanayama
Y
Asai
H
Yonezawa
T
Kitamura
Y
Galli
SJ
Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell deficient W/Wv mice: Evidence that cultured mast cells can give rise to both “connective tissue-type” and “mucosal” mast cells.
J Exp Med
162
1985
1025
17
Kitamura
Y
Heterogeneity of mast cells and phenotypic change between subpopulations.
Annu Rev Immunol
7
1989
59
18
Tsujimura
T
Morii
E
Nozaki
M
Hashimoto
K
Moriyama
Y
Takebayashi
K
Kondo
T
Kanakura
Y
Kitamura
Y
Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice.
Blood
88
1996
1225
19
Morii
E
Takebayashi
K
Motohashi
H
Yamamoto
M
Nomura
S
Kitamura
Y
Loss of DNA binding ability of the transcription factor encoded by the mutant mi locus.
Biochem Biophys Res Commun
205
1994
1299
20
Morii
E
Tsujimura
T
Jippo
T
Hashimoto
K
Takebayashi
K
Tsujino
K
Nomura
S
Yamamoto
M
Kitamura
Y
Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus.
Blood
88
1996
2488
21
Takebayashi
K
Chida
K
Tsukamoto
I
Morii
E
Munakata
H
Arnheiter
H
Kuroki
T
Kitamura
Y
Nomura
S
Recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nuclear localization potential.
Mol Cell Biol
16
1996
1203
22
Reynolds
DS
Stevens
RL
Lane
WS
Carr
MH
Austen
KF
Serafin
WE
Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases.
Proc Natl Acad Sci USA
87
1990
3220
23
Reynolds
DS
Stevens
RL
Lane
WS
Carr
MH
Austen
KF
Serafin
WE
Isolation and molecular cloning of mast cell carboxypeptidase A: A novel member of the carboxypeptidase gene family.
J Biol Chem
264
1989
20094
24
Serafin
WE
Sullivan
TP
Condar
GA
Ebrahimi
A
Marcham
P
Johnson
SS
Austen
KF
Reynolds
DS
Cloning of the cDNA and gene for mouse mast cell protease 4: Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat.
J Biol Chem
266
1990
1934
25
McNeil
HP
Austen
KF
Somerville
LL
Gurish
MF
Stevens
RL
Molecular cloning of the mouse mast cell protease-5 gene: A novel secretory granule protease expressed early in the differentiation of serosal mast cells.
J Biol Chem
266
1991
20316
26
Reynolds
DS
Gurley
DS
Austin
KF
Serafin
WE
Cloning of the cDNA and gene of mouse mast cell protease-6: Transcription by progenitor mast cells and mast cells of the connective tissue subclass.
J Biol Chem
266
1991
3847
27
Huang
R
Blom
TM
Hellman
L
Cloning and structural analysis of mMCP-1, mMCP-4, and mMCP-5, three mouse mast cell specific serine proteases.
Eur J Immunol
21
1991
1611
28
McNeil
HP
Reynolds
DS
Schiller
Y
Ghildyal
N
Gurley
DS
Austen
KF
Stevens
RL
Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7.
Proc Natl Acad Sci USA
89
1992
11174
29
Ghildyal
N
McNeil
HP
Stechschulte
S
Austen
KF
Silberstein
D
Gurish
MF
Somerville
LL
Stevens
RL
IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice.
J Immunol
149
1992
2123
30
Gurish
MF
Nadeau
JH
Johnson
KR
McNeil
HP
Grattan
KM
Austen
KF
Stevens
RL
A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14.
J Biol Chem
268
1993
11372
31
Heusel
JW
Scarpati
EM
Jenkins
NA
Gilbert
DJ
Copeland
NG
Shapiro
SD
Ley
TJ
Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene.
Blood
81
1993
1614
32
Brunet
JF
Dosseto
M
Denizot
F
Mattei
MG
Clark
WR
Haqqi
TM
Ferrier
P
Nabholz
M
Schmitt-Verhulst
AM
Luciani
MF
Golstein
P
The inducible cytotoxic T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization to mouse chromosome 14.
Nature
322
1986
268
33
Crosby
JL
Bleackley
RC
Nadeau
JH
A complex of serine protease genes expressed preferentially in cytotoxic T-lymphocytes is closely linked to the T-cell receptor α- and δ-chain genes on chromosome 14.
Genomics
6
1990
252
34
Nakahata
T
Spicer
SS
Cantey
JR
Ogawa
M
Clonal assay of mouse mast cell colonies in methylcellulose culture.
Blood
60
1982
352
35
Mann
R
Mulligan
RC
Baltimore
D
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.
Cell
33
1983
153
36
Tsujimura
T
Morimoto
M
Hashimoto
K
Moriyama
Y
Kitayama
H
Matsuzawa
Y
Kitamura
Y
Kanakura
Y
Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain.
Blood
87
1996
273
37
Laker
C
Stocking
C
Bergholz
U
Hess
N
DeLamarter
JF
Ostertag
W
Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.
Proc Natl Acad Sci USA
84
1987
8458
38
Graham
FL
Van der Eb
AJ
A new technique for the assay of infectivity of human adenovirus 5 DNA.
Virology
52
1973
456
39
Auffray
C
Rougenon
F
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.
Eur J Biochem
107
1980
303
40
Tokunaga
K
Taniguchi
H
Yoda
K
Shimizu
M
Sakiyama
S
Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.
Nucleic Acids Res
14
1986
2829
41
Jippo
T
Tsujino
K
Kim
H-M
Kim
D-K
Lee
Y-M
Nawa
Y
Kitamura
Y
Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization.
Am J Pathol
150
1997
1373
42
Nomura
S
Wills
AJ
Edwards
DR
Heath
JK
Hogan
BLM
Developmental expression of 2ar (osteonectin) and SPARK (osteopontin) RNA as revealed by in situ hybridization.
J Cell Biol
106
1988
441
43
Nakajima
K
Kusafuka
T
Takeda
T
Fujitani
Y
Nakae
K
Hirano
T
Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter.
Mol Cell Biol
13
1993
3027
44
Schreiber
E
Matthias
P
Muller
MM
Schaffner
W
Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells.
Nucleic Acids Res
17
1989
6419
45
Pagano
M
Durst
M
Joswig
S
Draetta
G
Jansen
DP
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Oncogene
7
1992
1681
46
Ephrussi
A
Church
GM
Tonegawa
S
Gilbert
W
B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo.
Science
227
1985
134
47
Eklund
KK
Ghildyal
N
Austen
KF
Stevens
RL
Induction by IL-9 and supression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases.
J Immunol
151
1993
4266
48
Gurish
MF
Ghildyal
N
McNeil
HP
Austen
KF
Gillis
S
Stevens
RL
Differential expression of secretory granule proteases in mouse mast cells exposed to IL-3 and c-kit ligand.
J Exp Med
175
1992
1003
49
Xia
Z
Ghildyal
N
Austen
KF
Stevens
RL
Post-transcriptional regulation of chymase expression in mast cells.
J Biol Chem
271
1996
8747
50
Yasumoto
KI
Yokoyama
K
Shibata
K
Tomita
Y
Shibahara
S
Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.
Mol Cell Biol
14
1994
8058
51
Bentley
NJ
Eisen
T
Goding
CR
Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator.
Mol Cell Biol
14
1994
7996
52
Yavuzer
U
Keenan
E
Lowings
P
Vachtenheim
J
Currie
G
Goding
CR
The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription.
Oncogene
10
1995
123
53
Tachibana
M
Takeda
K
Nobuyuki
Y
Urabe
K
Long
JE
Meyers
KA
Aaronson
SA
Miki
T
Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.
Nat Genet
14
1996
50
54
Benezra
R
Davis
RL
Lockshon
D
Turner
DL
Weintraub
H
The protein Id: A negative regulator of helix-loop-helix DNA binding proteins.
Cell
61
1990
49
55
Rice
NR
MacKichan
ML
Israel
A
The precursor of NF-kappa B p50 has I kappa B-like functions.
Cell
71
1992
243
56
Rice
NR
Ernst
MK
In vivo control of NF-kappa B activation by I kappa B alpha.
EMBO J
12
1993
4685
57
Nechushtan
H
Zhang
Z
Razin
E
Microphthalmia (mi ) in murine mast cells: Regulation of its stimuli-mediated expression on the translational level.
Blood
89
1997
2999
58
Eklund
KK
Ghildyal
N
Austen
KF
Friend
DS
Schiller
V
Stevens
RL
Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates.
J Exp Med
180
1994
67
Sign in via your Institution